It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

AstraZeneca

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
AstraZeneca’s Japan partner to go solo on future cancer drugs

Business / Corporate Jun 7, 2023

AstraZeneca’s Japan partner to go solo on future cancer drugs

by Kanoko Matsuyama

Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.

Japan OKs third Pfizer shot for children and AstraZeneca COVID treatment

National / Science & Health Aug 30, 2022

Japan OKs third Pfizer shot for children and AstraZeneca COVID treatment

by Tomoko Otake

Children between the ages of 5 and 11 will be able to get the booster shot five months or more after they received their second dose.

The drug that could transform breast cancer treatment

Commentary / World Jun 8, 2022

The drug that could transform breast cancer treatment

by Lisa Jarvis

The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.

Japan cancels purchase of 40 million Astrazeneca vaccine doses

National / Science & Health Apr 11, 2022

Japan cancels purchase of 40 million Astrazeneca vaccine doses

The government had originally agreed to buy 120 million of the shots, with the bulk made domestically by Daiichi Sankyo Co. and other local partners.

Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?

National Feb 7, 2022

Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?

by Osamu Tsukimori

Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.

The ins and outs of Japan's COVID-19 booster shot rollout

National | EXPLAINER Jan 6, 2022

The ins and outs of Japan's COVID-19 booster shot rollout

by Osamu Tsukimori

Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

Commentary / World Nov 26, 2021

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

by Therese Raphael

It's suggested that Britain’s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?

Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors

National Sep 14, 2021

Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors

Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.

Here’s how to treat COVID-19 vaccine side effects

Lifestyle Aug 22, 2021

Here’s how to treat COVID-19 vaccine side effects

by Haruka Murayama

There's no guarantee that you'll experience side effects from your COVID-19 vaccination, but it doesn't hurt to be prepared for them anyway.

Health ministry panel approves AstraZeneca’s vaccine for people 40 and over

National Jul 30, 2021

Health ministry panel approves AstraZeneca’s vaccine for people 40 and over

by Osamu Tsukimori

The panel also backed a proposal to make the shot available to people under age 40 who wish to get AstraZeneca’s jab or who are allergic to the ingredients of the mRNA vaccines.

Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds

World Jul 22, 2021

Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds

The study reiterated that one shot of the vaccines is not enough for high protection from the highly transmissible variant.

North Korea rejected AstraZeneca's COVID-19 vaccine over side effects, think tank claims

Asia Pacific Jul 10, 2021

North Korea rejected AstraZeneca's COVID-19 vaccine over side effects, think tank claims

North Korea has rejected planned shipments of AstraZeneca's COVID-19 vaccine that were being organized under the global COVAX distribution plan due to concerns over side effects, a South Korean think tank said Friday. COVAX has said it would provide nearly 2 million doses of AstraZeneca's ...

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times